After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of BioCardia Inc is $15.18M. A total of 94452.0 shares were traded on the day, compared to an average of 575.62K shares.
In the most recent transaction, STERTZER SIMON H bought 398,400 shares of BCDA for 1.25 per share on Sep 19 ’25. After the transaction, the Director now owns 591,054 company shares. In a previous transaction on Sep 19 ’25, Blank Andrew Scott bought 288,000 shares at 1.25 per share. BCDA shares that Director owns now total 634,023.
Among the insiders who bought shares, Altman Peter acquired of 48,000 shares on Sep 19 ’25 at a per-share price of $1.25. This resulted in the President and CEO holding 216,762 shares of BCDA after the transaction. In another insider transaction, Altman Peter bought 700 shares at $1.83 per share on Aug 22 ’25. Company shares held by the President and CEO now total 168,762.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BCDA has a high of $3.20 and a low of $1.00.
As of this writing, BCDA has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.2. The company reported an EPS of -$0.25 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BCDA’s latest balance sheet shows that the firm has $12.87M in Cash & Short Term Investments as of fiscal 2021. There were $1.87M in debt and $3.71M in liabilities at the time. Its Book Value Per Share was $0.25, while its Total Shareholder’s Equity was $10.38M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCDA is Buy with a score of 4.00.
